Surgery Improves Relapsed Ovarian Cancer Survival

The standard of care in relapsed ovarian cancer typically is treatment with systemic chemotherapy. But in a recent trial, women with recurrent ovarian cancer had longer overall survival when they had secondary cytoreductive surgery followed by chemotherapy instead of chemotherapy alone.